Final Program - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

ASGCT Officers and Board of Directors President Xandra O. Breakeield, PhD President-Elect David W. Russell, MD, PhD Vice President Harry L. Malech, MD Secretary John J. Rossi, PhD Treasurer David V. Schaffer, PhD Board Members Chiara Bonini, MD Barry J. Byrne, MD, PhD Fabio Candotti, MD Roberto Cattaneo, PhD Marina Cavazzana-Calvo, MD, PhD Jeffrey Chamberlain, PhD Brendan Lee, MD, PhD John J. Nemunaitis, MD Xiao Xiao, PhD Ex-Oficio Board Members Malcolm K. Brenner, MD, PhD Katherine P. Ponder, MD Table of Contents A Welcome from Xandra O. Breakeield, PhD ................2 Annual Meeting Exhibitors ....................................................3 Annual Meeting Supporters ..................................................4 Committee Meeting Schedule and Rosters ....................6 Abstract Planning Committee & Reviewers ................ 12 Excellence in Research Awards & Travel Grant Recipients .................................................. 14 Award Recipients .................................................................... 15 Faculty List ................................................................................ 16 General Meeting Information ............................................ 22 Hotel Information and Area Map ..................................... 26 Convention Center Plans...................................................... 27 Schedule-at-a-Glance ............................................................. 30 Program Schedule ................................................................... 31 Exhibit Hall Floor Plan .......................................................... 78 Exhibitor Descriptions .......................................................... 79 Exhibitor Information ........................................................... 86 ASGCT Executive Office 555 East Wells Street, Suite 1100 Milwaukee, Wisconsin 53202 Phone: 414.278.1341 Fax: 414.276.3349 Email: info@asgct.org Website: www.asgct.org Abstract Directory .................................................................. 87 Abstract Author Index ........................................................ 139 Mary Dean, JD, CAE Executive Director Ken Janowski Education & Meetings Manager Shaun Kramer Marketing & Outreach Manager Tara Withington, CAE Consulting Partner David Wood Senior Program Manager Rebecca Zimmer Membership & Administrative Coordinator Final Program SALT LAKE CITY, UTAH May 15–18, 2013 1
A Welcome from Xandra O. Breakefield, PhD Dear Colleagues, Welcome to the American Society of Gene & Cell Therapy (ASGCT) 16th Annual Meeting! Salt Lake City’s rich history in the study of genetics and genealogy makes it a perfect city to feature this year’s latest advancements in our vibrant ield. The environs are also rich in majestic state parks and I hope you will take advantage of the chance to visit them, including Antelope Island State Park, as well as a guided tour of Temple Square on May 14 as part of an ASGCT networking adventure series. The program this year relects the increasing focus on reaching the commercialization phase of gene and cell therapeutics. On Wednesday evening, the Outreach Committee and BioIndustry Liaison Committee developed a two hour workshop on commercialization to discuss the low of funding in pipeline development along with some of the key conditions that must be in place in order to insure appropriate and eficient utilization of resources. On Saturday, the Translational Science & Product Development Committee will explore the unique issues we face in manufacturing biologics. Lastly, the BioIndustry Liaison Committee has organized a symposium on Friday comprising a series of talks and panel discussion aimed towards the latter steps of commercialization. In addition, we will continue to focus on our historic strengths in novel technologies in delivery platforms for oligonucleotide, gene and cell therapies, as well as advances in preclinical and clinical trials, with important breakthroughs on many fronts. I hope you will be able to stay for the full four days of programming, including the series of evening symposia sponsored by our foundation partners – the Foundation Fighting Blindness, the Muscular Dystrophy Association, the French Muscular Dystrophy Association, and the Alliance for Cancer Gene Therapy. My special thanks to all the ASGCT members, exhibitors, sponsors and attendees who are making this such an exciting meeting! Sincerely, Xandra O. Breakeield, PhD President, ASGCT 2 Final Program SALT LAKE CITY, UTAH May 15–18, 2013
Page 4 and 5: Annual Meeting Exhibitors - as of A
Page 6 and 7: Annual Meeting Supporters Patron Le
Page 8 and 9: Committee Rosters Advisory Council
Page 10 and 11: Committee Rosters Host Committee Ch
Page 12 and 13: Committee Rosters Program Committee
Page 14 and 15: Abstract Reviewers Cancer - Immunot
Page 16 and 17: Outstanding New Investigator Awards
Page 18 and 19: Faculty List Thomas W. Chalberg, Jr
Page 20 and 21: Faculty List Ann M. Leen, PhD Baylo
Page 22 and 23: Faculty List Evan Y. Snyder, MD PhD
Page 24 and 25: General Meeting Information Continu
Page 26 and 27: General Meeting Information Speaker
Page 28 and 29: Salt Palace Convention Center Floor
Page 30 and 31: Salt Palace Convention Center Floor
Page 32 and 33: Program Schedule, Wednesday, May 15
Page 48 and 49: Program Schedule, Thursday, May 16,
Page 50 and 51: Program Schedule, Thursday, May 16,
Page 52 and 53:
Program Schedule, Thursday, May 16,
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Program Schedule, Friday, May 17, 2
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Program Schedule, Saturday, May 18,
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Exhibitor Descriptions Aldevron 323
Page 82 and 83:
Exhibitor Descriptions HypOxygen 51
Page 84 and 85:
Exhibitor Descriptions Panasonic He
Page 86 and 87:
Exhibitor Descriptions University o
Page 88 and 89:
Abstract Directory, Wednesday, May
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Abstract Directory, Thursday, May 1
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Abstract Directory, Friday, May 17,
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Abstract Directory, Saturday, May 1
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Abstract Author Index Aartsma-Rus,
Page 142 and 143:
Abstract Author Index Bartel, Ronnd
Page 144 and 145:
Abstract Author Index Bridges, Char
Page 146 and 147:
Abstract Author Index Chicoine, Lou
Page 148 and 149:
Abstract Author Index Daukandt, Mar
Page 150 and 151:
Abstract Author Index Eleftheriadou
Page 152 and 153:
Abstract Author Index Furth, Mark E
Page 154 and 155:
Abstract Author Index Grosso, Chant
Page 156 and 157:
Abstract Author Index Hickey, Ray D
Page 158 and 159:
Abstract Author Index Jacobs, Edwin
Page 160 and 161:
Abstract Author Index Kildebeck, Er
Page 162 and 163:
Abstract Author Index Lankester, Ar
Page 164 and 165:
Abstract Author Index Ling, Changqu
Page 166 and 167:
Abstract Author Index Martin, Dougl
Page 168 and 169:
Abstract Author Index Morishita, Na
Page 170 and 171:
Abstract Author Index Okamoto, Sach
Page 172 and 173:
Abstract Author Index Potter, Phil
Page 174 and 175:
Abstract Author Index Ruggiero, Eli
Page 176 and 177:
Abstract Author Index Shirakawa, To
Page 178 and 179:
Abstract Author Index Swanson, Magd
Page 180 and 181:
Abstract Author Index Ugai, Hideyo.
Page 182 and 183:
Abstract Author Index Watts, Korash
Page 184 and 185:
Abstract Author Index Yanovich, Sau
show all

Final Program - American Society of Gene & Cell Therapy

Create successful ePaper yourself

Delete template?

Save as template?